Patent · US Active

Chimeric Newcastle disease viruses and uses thereof

US8591881B2 · kind B2 · utility

9Cited by

11References

16Claims

0Family size

Assignees

Mount Sinai School of Medicine · US
Memorial Sloan Kettering Cancer Center · US

Inventors

Peter Palese · Leonia, US
Adolfo Garcia-Sastre · New York, US
Dmitriy Zamarin · New York, US
Yuman Fong · Duarte, US

Key dates

Filing date	Feb 5, 2010
Grant date	Nov 26, 2013
Priority date	—
Expiry date	Mar 26, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are chimeric Newcastle disease viruses engineered to express a heterologous interferon antagonist and compositions comprising such viruses. The chimeric Newcastle disease viruses and compositions are useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.